Dynamic control of maternal blood flow to the placenta is critical for healthy pregnancy. In many tissues, microvasculature arteries control the flow. The uterine/endometrial vascular bed changes during pregnancy include physiological remodeling of spiral arteries from constricted artery-like structures to dilated vein-like structures between Gestation Day 8 (gd8) and gd12 in mice and wk 12-16 in humans. These changes occur, in part, due to local environmental changes such as decidualization, recruitment of maternal uterine natural killer cells, and invasion of conceptus-derived trophoblasts. No current preparations permit in vivo testing of decidual microvascular reactivity. We report an in vivo intravital fluorescence microscopy model that permits functional study of the entire uterine microvascular bed (uterine, arcuate, radial, basal, and spiral arteries) in gravid C57BL/6 mice. Vascular reactivities were measured at gd8 prespiral arterial remodeling and gd12 (postremodeling) to a range of concentrations of adenosine (10 À8 -10 À6 M), acetylcholine (10 À7 -10 À5 M), phenylephrine (10 À7 -10 À5 M), and angiotensin II (10 À8 -10 À6 M). At baseline, each arterial branch order was significantly more dilated on gd12 than gd8. Each microvascular level responded to each agonist on gd8 and gd12. At gd12, vasodilation to adenosine was attenuated in uterine, arcuate, and basal arteries, while constrictor activity to angiotensin II was enhanced in uterine and arcuate arteries. The tendency for increasing vasoconstriction between gd8 to gd12 and the constrictor responses of modified spiral arteries were unexpected findings that may reflect influences of the intact in vivo environment rather than inherent properties of the vessels and may be relevant to ongoing human pregnancies.
INTRODUCTION
Pregnancy presents unique cardiovascular challenges. One such challenge is the development of vascular support for the growing placenta, the organ responsible for the exchange of nutrients and waste products between fetal and maternal circulations. Adequate blood flow and placental development are critical to fetal and maternal health. For example, 3%-5% of pregnant women develop the hypertensive syndrome preeclampsia [1] and require emergency, often preterm, delivery of the placenta and its associated fetus. A key step suspected in development of preeclampsia is restriction of blood flow to the placenta associated with incomplete spiral artery remodeling [2] . Although blood flow to the human placenta can be measured [3] , the determinants controlling blood flow to the placenta are undefined.
Control of vascular perfusion within tissue is generally attributed to small arteries and arterioles [4, 5] . In skeletal muscle, control of capillary recruitment and tissue perfusion at rest and during contraction is attributed to the terminal arteriolar microvessels [6] [7] [8] [9] [10] . Arteriolar vascular diameters are environmentally influenced by neural, humoral, and locally released tissue factors. It is hypothesized that local tissue influences increase when skeletal muscle increases its metabolism, thus, linking tissue metabolism and blood flow (for a review, see [11, 12] ).
Maternal blood flow to the placenta travels through the uterine artery terminal microvasculature that includes the uterine, arcuate, radial, and spiral arteries that feed the conceptus and basal arteries that feed the endometrium [2, 13, 14] (Fig. 1A) . Maternal spiral arteries undergo significant structural modification and enlargement about midgestation. Modifications appear to be initiated by uterine natural killer (uNK) cells [15] [16] [17] [18] [19] and completed by intramural and intravascular trophoblast cells in both humans and mice [2, 20, 21] . Because of the unique cyclic rebuilding of the terminal microvasculature of the uterine artery due to menstrual and estrous cycles and following pregnancy, it cannot be assumed that regulatory mechanisms defined in skeletal muscle will apply to the uterine microvasculature during pregnancy.
Most studies addressing regulation of the uterine vasculature use explanted vessels tested as sliced rings or wire myography. For the latter studies, surrogate vessels such as the omentum are frequently used. At present, no methodology studies maternal uterine microvasculature reactivity in their native environment. Here, we report the development of a model to visualize intact, in vivo, blood-perfused, decidual, terminal arteriolar microvessels using intravital microscopy. We determined the reactivity of each level of the uterine microvasculature to agonists at Gestation Day 8 (gd8), prior to spiral artery remodeling (Fig. 1C) , and gd12, postremodeling (Fig. 1E) . The results in intact animals are discordant with those from arterial explant studies. We show that the radical modification of spiral arteries necessary to enhance blood flow to the placenta during fetal development does not sacrifice contractile function of this vessel.
MATERIALS AND METHODS

Animals
C57BL/6/NCrl (B6) wild-type mice (n ¼ 30) from Charles River were housed under normal husbandry at the University of Guelph. Nulliparous female mice aged 8-14 wk were paired overnight with syngenic males. Presence of a copulatory plug in the morning was considered gd0 and mated [13] , and Osol and Mandela (human and mouse) [62] . Bold arrow indicates direction of blood flow. DB: decidua basalis; MLAp: mesometrial lymphoid aggregate of pregnancy. B) Photomontage of the uterine vasculature at gd8 using intravital microscopy. Arterial endothelium were stained with Alexa Fluor 488 conjugated to isolectin from G. simplicifolia. Ci) Typical appearance of the mesometrial side of a gd8 implant site dually stained with DBA lectin and PAS. Uterine artery (UA) entry is LEONARD ET AL.
females were housed individually until used for experiments. Food and water were provided ad libitum. All the experimental protocols were approved by the University of Guelph's Animal Care Committee in accordance with the guidelines of the Canadian Council on Animal Care.
Surgical Preparation for In Vivo Intravital Microscopy of the Endometrial Vasculature
Mice (gd8 or gd12) were anesthetized with 70 mg/kg sodium pentobarbital intraperitoneally. The mice underwent a tracheotomy and catheterization whereby polyethylene catheters (internal diameter ;25-35 lm) were inserted into the right jugular vein for supplemental anesthetic (70 mg/kg), the left common carotid artery to monitor mean arterial pressure (MAP), and the left femoral vein for administration of fluorescent dye (see below). Mice were placed supine on a lucite board fitted with a heated water coil at 428C to maintain esophageal temperature at 378C. A 2 cm incision was made ventrally to gain access to the uterus, originating from the caudal-most nipples and bisecting the abdomen. One uterine horn was selected and exteriorized. The mouse was turned onto the right side and the uterine horn secured to a custommade silicone (Siligard; WPI) pedestal at both ends with insect pins. The gd8 preparations were oriented such that the antimesometrial surface was laid against the silicone and pinned so the vasculature entered the implantation site from the top; this orientation allowed for unobstructed blood flow and ideal visualization of the vasculature. For gd12, the fetus had to be separated from the uterine tissue (due to its size) in order to orient the preparation as described above. To remove the fetus, an incision was made along the antimesometrial side of the uterine horn. The antimesometrial tissue was retracted to expose three amniotic sacs. The embryo proper and amniotic membranes were excised from these implantation sites to facilitate the necessary tissue orientation of the center site of interest on the silicone pedestal. The uterine tissue was secured in place with insect pins through the antimesometrial uterine tissue remaining.
The exteriorized uterus was continuously superfused with a bicarbonatebuffered physiological salt solution (PSS) containing 131.9 mM NaCl, 4.7 mM KCl, 2.0 mM CaCl 2 , 1.2 mM MgSO 4 , and 30 mM NaHCO 3 maintained at 378C and equilibrated with a 5% CO 2 -95% N 2 gas mixture to a pH of 7.4 6 0.05. The superfusate was supplemented with 10 À9 M isoproterenol (Sigma-Aldrich) to decrease uterine smooth muscle motility [22] . Once the surgical preparation was complete, the mouse was transferred to the microscope, and the vasculature was allowed to acclimate for 45-60 min prior to experimental protocols.
Experimental Protocols
At 15 min prior to the experimental protocols, a 0.4 ml bolus injection of fluorescent dye Alexa Fluor 488 conjugated to isolectin GS-IB 4 from Griffonia simplicifolia (166 lg/ml; Invitrogen) to label the endothelial cells of the microvasculature was administered via the femoral catheter. The full volume was injected over 10-15 sec. A slight increase in MAP was typical following the bolus injection but MAP was quickly reestablished to normal.
For all the experimental protocols, the fluorophore was excited with a 100 W mercury-arc lamp using a 480 6 20 nm narrow bandpass filter and emissions were recorded using a 535 6 30 nm narrow bandpass filter. Fluorescent emissions were collected with a linear 12-bit black and white cooled charge-coupled device camera (Roper CoolSnap HQ; Photometrics) mounted on a modified Olympus BX51WI microscope (Olympus Corp.) using either a 43 objective (numerical aperture of 0.13) or a 103 (numerical aperture of 0.30) long working distance objective with a 1.63 magnification changer. The final magnification of the vasculature was ;10003.
Prior to drug application, a set of low magnification images was taken of the vascular network (similar to those in Fig. 1 , B and D) to ensure consistency in the classification of branch orders. Images were captured at high magnification of each site of interest for measurement of baseline diameter. Images were captured using Image Pro Plus software (Media Cybernetics) and saved for offline analysis. The endometrial tissue was then topically exposed to the lowest concentration of a randomly selected agonist via the superfusate. The agonists used were 10 À8 -10 À6 M angiotensin (AngII) and 10 À7 -10 À5 M phenylephrine (PHE) as vasoconstrictors, and 10 À7 -10 À5 M acetylcholine (ACh) and 10 À8 -10 À6 M adenosine (ADO) as vasodilators. Each preparation was tested with one or two agonists; for the latter case, one vasodilator and one vasoconstrictor were randomly selected as was the agonist application order. The initial concentration of agonist was applied via the superfusate (agonist þ PSS) for 2 min (4 min for AngII), and then images were captured at each vessel segment of interest in the continued presence of the agonist. The subsequent concentration was immediately applied for 2 min (4 min for AngII), and again images were captured at each vessel of interest. This was repeated once more for the final concentration. The agonist was then washed out with PSS for 1 h prior to administration of the second agonist, when applicable. At the completion of the protocols, maximum vasodilations were induced with 10 À4 M sodium nitroprusside (SNP), a nitric oxide donor, and images of each vessel segment of interest were captured.
Histology
Archived, paraffin-embedded implantation sites (4% paraformaldehyde fixed by perfusion) from gd8 and gd12 B6 mice previously reported as typical [23] were sectioned at 6 lm, dually stained with DBA lectin and periodic acid Schiff (PAS) reagent to identify uNK cells as described elsewhere [24] , or with tetramethylrhodamine isothiocyanate (TRITC)-conjugated DBA lectin (Vector Laboratories Inc.) and Alexa Fluor 488-conjugated anti-mouse actin (eBioscience, Inc.). For immunofluorescence, sections (n ¼ 2 pregnancies and 4 total implantation sites/gestational day) were deparaffinated, hydrated, washed with PBS, blocked 30 min with 1% bovine serum albumin (BioShop) diluted in PBS, and washed and incubated overnight (48C) with anti-mouse actin (10 lg/ ml). Sections were then washed and incubated with TRITC-DBA lectin (5 lg/ ml) for 40 min at room temperature. Nuclei were visualized by 4 0 ,6-diamidino-2-phenylindole (DAPI) staining using ProLong Gold antifade reagent containing DAPI (Invitrogen Life Technology). Tissues were studied, photographed, and annotated using an AxioImager M.1 microscope and Axiovision software (Carl Zeiss).
Data and Statistical Analysis
Vessel diameters were measured using calibrated Image Pro software. All the data are expressed as mean 6 SEM. Arterial diameters are expressed as change in diameter from baseline in micrometers. Only one artery of each branch order per endometrial preparation was used, and n indicates the number of arteries observed. Group means were compared first with a two-way ANOVA to determine interactions between drug concentrations and gestational day, where applicable. Subsequently a repeated measures ANOVA was performed for each variable. When the significance reached P 0.05, a protected least squares difference test was used post hoc to test the group means. Because of differences observed in baseline diameters (Table 1) , linear regression analysis was used to determine correlations between either the initial baseline diameter or the dilatory potential (maximum diameter À baseline diameter) of the arteries and the response to the lowest dose of each drug.
3 positioned uppermost; representative coils are marked by arrowheads. Smaller diameter arteries (cut in cross section) near the two-layered myometrium (Myo) include arcuate and radial arteries. Spiral arteries (SA, examples are boxed) occur in the decidua basalis (DB) closer toward ectoplacental cone trophoblasts (T). Embryo cavity (EC), residual uterine lumen and DBAþ yolk sac endothelium are identified. Two high-power inserts of SA (insets 1 and 2) show the thickness of the walls (outlined) relative to the lumen and the proximity of numerous PASþDBAÀ (purple only) and PASþDBAþ (purple plus brown) uNK cells. Diameters of uNK cells in DB are known to be greater than diameters of uNK cells nearer the myometrium [57] . D) Photomontage of the uterine vasculature at gd12 using intravital microscopy. Arterial endothelium were stained as in B. Ei) Typical appearance of the mesometrial side of a gd12 implant site dually stained with DBA lectin and PAS. Entry of the now dilated uterine artery is positioned uppermost. Differentiation of the uNK cellenriched MLAp at each implant site separates the two layers of myometrium and rings the uterine artery. The DB and the mature placenta (PL) are identified. Spiral arteries in the DB are boxed; red arrows indicate SA. High-power image (1) shows the uterine artery in the MLAp and its association with PASþDBAÀ (purple only) and PASþDBAþ (purple plus brown) uNK cells. The uterine artery is outlined to highlight the thickness of wall artery, relative to the lumen. High-power image (2) shows the remodeled SA from the center of DB and its associated PASþDBAþ (purple plus brown) uNK cells. PASþDBAÀ uNK cells are rare in this region by gd12.5. The SA wall/lumen ratios are reduced compared to gd8 (images are at the same magnification). Bars ¼ 100 lm (B, Ci, D, and Ei) and 20 lm (insets 1 and 2 in Ci and Ei).
DECIDUAL VASCULAR REACTIVITY IN VIVO
RESULTS
Visualization and Branch Order Classification of the Endometrial Vasculature
Isolectin GS-IB 4 from G. simplicifolia (specific for terminal a-D-galactosyl moieties) conjugated to Alexa Fluor 488 brightly visualized B6 endothelium of the mesometrial uterine and decidual vasculature, permitting identification of vessel branch order and diameter measurements (Fig. 1, B and D) . In skeletal muscle vasculature (cremaster), preliminary studies showed that isolectin GS-IB 4 Alexa Fluor 488 dye had no effects on baseline diameters or on agonist-induced responses. Figure 1 , B and D, depict photomontages of myometrial vessels from of gd8 and gd12 implant sites. The uterus is supplied by the main uterine artery loop within the mesenteric connective tissue; branches from this main supply segmentally enter the myometrium and supply microvascular units to mucosa and, during pregnancy, to implant sites. These branches are termed uterine arteries; within the uterus, they branch transversely into arcuate arteries (Fig. 1A) . The arcuate arteries supply daughter branches, radial arteries that penetrate deeper into the myometrium. Near the boundary of the decidua basalis, radial arteries branch into both spiral arteries that supply the fetus, and basal arteries that provide flow to endometrial tissue.
Localized areas of constriction were commonly observed at many levels of the microvasculature (Fig. 2) at gd12 but rarely at gd8. These appear similar to the radial artery circumferential bands noted in gd14.5 CD1 mice by Adamson et al. [13] using vascular casting. We observed that the focal constrictions were static in position and decreased the diameter of the vessel by 21.3% 6 2.4%. The focal constrictions were reactive, decreasing in diameter in response to 10 À6 M PHE (19.5% 6 3.1%) to the same degree as the vessel diameter near the focal constriction (21.3% 6 2.4%). The focal constrictions vasodilated in response to 10 À4 M SNP to produce maximal dilation but only dilated to 79.2% 6 3.4% of the diameter of its resident vessel.
Vascular Baseline and Maximum Diameters
At gd8, baseline diameters across all the branch orders were similar except the basal arteries were significantly smaller (Table 1) . At gd8, maximum diameters following SNP administration were all significantly greater for all the branch orders than the respective baseline diameters. At gd8, all levels of the uterine arterial tree rested at ;80% of maximum diameter.
At gd12, baseline diameters of all the branch orders were significantly greater than at gd8 except for the uterine artery.
Maximum diameters for all the branch orders were not significantly different between gd12 and gd8 except for the spinal arteries. At gd12, resting arteries were more dilated/less vasoconstricted than at gd8 because the baseline diameters represented a significantly greater percentage of maximum diameters for each branch order (calculated as ;10% increase; Table 1 ). In stark contrast to the other branch orders, the spiral arteries had ;2-fold increase in both baseline and maximum diameters at gd12 compared to gd8. This large change indicates extensive spiral artery growth and/or remodeling and confirms the correct classification of branch orders. Of note, the baseline diameter of the spiral arteries at gd12 was less than maximal (as determined by comparing baseline diameter to diameter in the presence of the maximal dilating concentrations of SNP).
Significant differences in baseline diameters within each branch order between gd8 and gd12 may suggest that the smooth muscle of the vessel wall is at a different length and may possibly affect the response to agonists. The lack of correlations between baseline diameters and the measured agonist-induced responses (average r 2 values for gd8 were 0.32 6 0.07 and for gd12 were 0.21 6 0.06) indicated that differences in baseline diameters (i.e., smooth muscle length) within branch orders between gd8 and gd12 were not important determinants of the measured agonist-induced responses.
Uterine Vascular Responses to Vasoactive Agonists at gd8 and gd12
Vasodilatory reactivities of the uterine vasculature were assessed with ACh and ADO. Given the resting baseline diameter of gd12 vessels (Table 1) , very little dilatory potential (maximum diameter À baseline diameter) was available (maximum diameter was determined using 10 À4 M SNP). Exposure to the highest concentration of either dilator caused the vessels to reach maximal diameter. Acetylcholine, an endothelial cell-dependent vasodilator, induced significant vasodilations (Fig. 3, A-E) with no significant difference between gd8 and gd12 for any arterial branch order. Conversely, ADO reactivity tended to decrease in uterine, arcuate, and radial arteries at gd12 compared to gd8, while spiral and arterial reactivities to ADO remained constant (Fig.  3, F-J) .
AngII induced significant vasoconstrictions in all branch orders observed at both gestational days. Figure 4 displays high magnification images of gd12 AngII responsive radial, basal, and spiral arteries. The spiral arteries at gd12 showed similar, potent reactivity to all concentrations of AngII as did the radial and basal arteries, while AngII reactivity within gd12 uterine and arcuate arteries was significantly increased compared to gd8 (Fig. 5, A-E) . Reactivities to increasing concentrations of * Diameters are expressed as mean 6 SEM. At gd12, spiral artery baseline and maximum diameters were always significantly larger than all other branch orders. z Basal artery baseline and maximum diameters were always significantly smaller than all the other branch orders within each gestational day. a Denotes significantly different from baseline diameter at gd8 or gd12. b Denotes significantly different from gd8.
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PHE were generally similar at gd8 and gd12 (Fig. 5, F-J ) except for arcuate arteries that showed increased sensitivity. Again, the gd12 spiral arteries remained similarly and significantly reactive to all concentrations of PHE tested.
Gestational Day 12 Spiral Arteries Lack Detectable Smooth Muscle Actin
Because of the unexpected vasoreactive responsiveness of modified spiral arteries, immunohistochemical studies were undertaken to determine whether vascular smooth muscle expressing cells still persisted at gd12. Strong actin expression was detected in the myometrium of all the specimens and served as a positive control. At gd8 and gd12, walls of the uterine artery were smooth muscle actin reactive (Fig. 6, A and  B) . The walls of uterine artery branches just inside of the myometrium (putatively identified as radial arteries by size and location) contained some actin reactive smooth muscle cells at gd8 and gd12 (Fig. 6, C and D) . Substantial numbers of uNK cells were associated with these vessels on gd12. Spiral arteries identified by location at gd8 expressed actin; however, gd12 spiral arteries did not (Fig. 6, E-H) . At both gd8 and 12, uNK cells appeared to interact with cells of the spinal arterial walls and lumens.
DISCUSSION
The process of gestational structural modification of human and mouse spiral arteries has been addressed extensively using ultrasonography, histopathology, and explant studies, but an understanding of the integrated functional capacity of the uterine arterial tree has not previously been available. We successfully developed a pregnant mouse preparation for in vivo viewing of the uterine vasculature that permits functional comparisons between segments of this microvascular tree. We characterized the baseline features of this circulatory unit and the responses of its subcomponents (uterine, arcuate, radial, basal, and spiral arteries) to agonists at times prior to histological detection of spiral arterial remodeling and after histological evidence for completion of spiral arterial remodeling [19, 25] . A strength of this intravital microscopy preparation is that all native physiological regulators of vessel diameter remain intact, including humoral, neuronal, and local mediators. For example, arterial diameters were characterized within the mesometrial lymphoid aggregate of pregnancy (MLAp), an area highly enriched in uNK cells that have perivascular, intramural, and intravascular locations [26] (Fig.  1, C and E) . The uNK lineage includes angiogenic subsets with potential vasoregulatory roles producing nitric oxide (mouse [27] ), ANP (mouse [28] ), vascular endothelial and placental growth factors in mouse and humans (e.g., see [29] [30] [31] [32] ), and vasodilatory cytokines (TNFa in rat [33] and mouse [34] and interferon gamma in mouse [35] ). Another major advantage of this preparation is that agents of interest can be applied to the uterine circulation, rather than systemically, to mimic local in vivo events that are more complex than reflected in culture.
Retention of physiological relationships between cells is important because baseline arterial diameters are established by complex interactions of multiple stimuli: signals arising from adjacent ''in contact'' cells, local signals arising within the tissue such as shear stress and paracrine mediators, and signals derived external to the site (such as circulating hormones, cytokines, chemokines, antigens, epigenetic regulators, and neurotransmitters). Tone was observed in all the segments of the uterine arterial tree before and after spiral arterial remodeling. The transition from early to midpregnancy increased baseline but not maximal diameters in all the segments except the spiral arteries. The latter showed increased maximal diameters after modification. These observations indicate a systematic vasodilation at each level of the microvasculature that would decrease uterine vascular resistance; the data is consistent with the known endometrial hemodynamics during this period [36] . Our data show that each level of the uterine microvasculature was responsive to ACh at both gd8 and gd12 with no significant change in sensitivity between gestation days of any branch order of the uterine microvasculature. An increase in sensitivity to ACh has been shown between the nonpregnant state and the pregnant state in the mesenteric uterine artery of different species using different vascular preparations [37] [38] [39] [40] [41] , and there is conflicting data as to what occurs throughout pregnancy. Pulgar et al. [42] using wire myography did not see a change in reactivity of uterine arteries to ACh between midand late gestation in mice, while Bell [43] using perfused uterine artery vessels observed an increased sensitivity throughout gestation in guinea pigs. Our data would indicate that if there are changes in endothelial cell nitric oxidedependent vasodilation, they are not due to events occurring around spiral artery modification.
The reactivity of the endometrial microvasculature to ADO in pregnancy has not been well defined. Studies suggest that ADO is a potent vasodilator of the mesenteric uterine artery in the nonpregnant state [44] in an endothelial-independent manner [45] although there are reports of ADO vasodilation through nitric oxide-dependent mechanisms [46] . We show that the uterine, arcuate, and radial arteries significantly decrease their reactivity to ADO by gd12. In skeletal muscle, ADO is an important mediator of local metabolic control of arterial diameter (for a review, see [47] ), with the source of ADO being the skeletal muscle cells themselves. The source of ADO in the uterus is not known although, during pregnancy, maternal plasma ADO is known to increase [48] . The importance of the change in reactivity to ADO will depend on sources and abundance of ADO throughout conceptus development.
We observed that each level of the uterine microvasculature constricted in the presence of PHE at both gd8 and gd12 and the arcuate and radial arteries became more responsive to PHE from gd8 to gd12. Mesenteric uterine arteries and branches from the mesenteric uterine artery have been shown to be more sensitive to PHE in pregnancy than in the nonpregnant state [49] [50] [51] [52] [53] although this observation is controversial [37, 41, [54] [55] [56] . Both the arcuate and radial arteries are located deeper in the MLAp region, which may be locally affected differently than vessels higher in the MLAp (uterine artery) region or predominantly in the decidua basalis (such as basal arteries and spiral arteries). These changes in reactivities of vessels in the MLAp coincide with high uNK localization in this region and may represent uNK cell-regulated effects (see Fig.1, C and E) . Both the arcuate and radial arteries are located more toward the longitudinal uterine muscle layer and visceral peritoneum. This location may be a distinctive environment to that of vessels (uterine artery) higher in the MLAp, a region enriched in immature, proliferative uNK cells or predominantly in decidua basalis (such as basal and spiral arteries), a region enriched in mature, post mitotic uNK cells [57] . Thus, changes in blood vessel reactivity may depend on the specific locations of the vessels within the endometrium and its resident influences.
In line with reports from mice [42] , humans [58] , and rats [51, 52, 59 ], we detected a significant increase in AngII reactivity within the endometrial microvasculature. The uterine and arcuate arteries increased their sensitivity to AngII between gd8 and gd12. As mentioned above, these changes in reactivities of vessels in the MLAp coincide with high uNK localization in this region and may represent uNK cellregulated effects. Because NK cells possess a functional renin-angiotensin system (RAS) [60] , uNK cells may be potential mediators of paracrine communication with the uterine microvasculature. RAS signaling promotes chemotactic effects on lymphocytes [60, 61] , which may represent a means of promoting maintenance of uNK cells in close proximity to these arteries and maintaining paracrine communication within the MLAp.
We observed focal constrictions at multiple levels of the uterine vasculature at gd12 and have further shown that focal constrictions are vasoactive. The development of focal constrictions from gd8 to gd12 could represent the beginning of a fundamental shift in blood flow control specific to implantation sites. Supporting this fundamental paradigm shift in control of blood flow, we found that gd12 spiral arteries remained reactive (despite confirmed extensive remodeling and loss of smooth muscle actin between gd8 to gd12) and gained reactivity to AngII following modification. Therefore, further investigation into both focal constrictions and spiral arterial reactivity postmodification will be required in order to understand their importance to blood flow control throughout fetal development.
The major contributions reported herein are: 1) the development of an intravital microscopy technique specifically adapted to visualize the in vivo reactivity of multiple levels of the endometrial microvasculature during mouse gestation; 2) the uterine vasculature becomes less vasoconstricted under baseline conditions between gd8 to gd12; 3) the arteries located within the MLAp show increases in AngII sensitivity and decreases in ADO sensitivity between gd8 and gd12; and 4) uNK cell-induced spiral artery remodeling does not affect spiral artery reactivity to any agonist tested. These data provide unique insights into the physiological vasoregulatory patterns of the uterine vasculature during mouse midgestation in regions that are dramatically modified over pregnancy and under the unique paracrine influences of uNK cells and trophoblasts. These findings challenge our current understanding of the functions of physiologically modified spiral arteries and should be considered when assessing modified human spiral arteries. Comparison of gd8 and gd12 changes in endometrial artery diameters in response to topically applied AngII (A-E) and PHE (F-J). The arterial response to the application of 10 À8 -10 À6 M AngII (gd8: n ¼ 7; gd12: n ¼ 8) in 4-min intervals on uterine artery (A), arcuate artery (B), radial artery (C), basal artery (D), and spiral artery (E). The arterial response to the application of 10 À7 -10 À5 M PHE (gd8: n ¼ 7; gd12: n ¼ 14) in 2-min intervals on uterine artery (F), arcuate artery (G), radial artery (H), basal artery (I), and spiral artery (J). All the responses are significantly different from baseline unless marked by a plus (þ), and a denotes significantly different (P , 0.05) from gd8 at the same concentration. Error bars represent the standard errors.
